Factor Ⅷ biosimilar (PanGen Biotech)

N/A

Report date: 2025/05/06 16:25:10

Base Information

Drug NameFactor Ⅷ biosimilar (PanGen Biotech)
Drug Alias NamePGA40PGA-40
ClassificationBiologics > Biosimilar
Mechanisms of ActionCoagulation factor VIII inhibitors
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPangen Biotech
China Registration ClassN/A

Develop Information

Active CompaniesPangen Biotech
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A